Lessons learned from the development of kinase inhibitors Journal Article
| Author: | Sawyers, C. L. |
| Article Title: | Lessons learned from the development of kinase inhibitors |
| Keywords: | vasculotropin; cancer survival; unclassified drug; gene mutation; clinical trial; drug tolerability; sorafenib; erlotinib; sunitinib; patient selection; drug targeting; animals; imatinib; melanoma; enzyme inhibition; breast cancer; gene expression profiling; protein kinase inhibitor; epidermal growth factor receptor 2; lung cancer; high throughput screening; drug screening; drug resistance, neoplasm; drug discovery; enzyme activity; abelson kinase; dasatinib; chronic myeloid leukemia; drug selectivity; mutational analysis; protein kinase inhibitors; patient care; drug research; dna; mammalian target of rapamycin; malignant neoplastic disease; dna sequence; antiinflammatory activity; pharmacogenetics; bcr abl protein; robotics; trastuzumab; nilotinib; protein kinase; b raf kinase; rapamycin; drug protein binding; scatter factor receptor; drug indication; plx 4032; drug industry; individualization; kidney graft rejection; kidney transplantation |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 7 |
| Issue: | 9 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2009-09-01 |
| Start Page: | 588 |
| End Page: | 589 |
| Language: | English |
| PUBMED: | 20020670 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 30 November 2010" - "Source: Scopus" |
